Navigation Links
Medical Research Award Goes to Adult Stem Cell Scientists at a Kansas Not-for-Profit Organization
Date:3/20/2008

WICHITA, Kan., March 20 /PRNewswire-USNewswire/ -- Scientists at the Bio-Communications Research Institute (BCRI), a division of The Center for the Improvement of Human Functioning International (CIHFI), received a prestigious award for a scientific article about its recent stem cell discovery. The scientific journal article entitled "Endometrial regenerative cells: A novel stem cell population" received BioMed Central's Research Article of the Year in Medicine Award sponsored by Microsoft Research. Dr. Xiaolong Meng, the lead author of the article and Associate Director of BCRI was in London, England yesterday to receive the award at the Royal Society of Medicine alongside Tom Ichim, co-author and CEO of MediStem Laboratories, Inc. The paper was published in November 2007 in the Journal of Translational Medicine. The award recognizes excellence in research that has been made universally accessible through open access publication in one of BioMed Central's peer reviewed scientific journals. The article is freely available at http://www.translational-medicine.com/content/5/1/57.

BCRI led the research team, composed of U.S. and Canadian scientists who identified and characterized a new type of stem cell that can be reproducibly isolated from menstrual blood collected from healthy women.

"We are extremely proud of the international recognition our scientists and collaborators are receiving for the discovery of this new type of stem cell," said Dr. Neil Riordan, co-author and President of MediStem, http://www.medisteminc.com. "We believe that these adult stem cells, which we have termed endometrial regenerative cells (ERC), offer a novel alternative to embryonic stem cells which are fraught with scientific and ethical issues."

"The ERC population appears to be superior to other stem cell types. These cells do not require matching with the recipient, they home to areas of injury or tissue damage, and they can differentiate into most of the tissue types found in the body," said Dr. Xiaolong Meng.

About BCRI: BCRI is actively involved in multiple research projects, ranging from converting adult stem cells into natural killer cells (potent anti-tumor cells), the effects of nutrients on adult stem cells, and cutting edge cancer research. BCRI is a division of The Center for the Improvement of Human Functioning International, Inc. and relies on donations from individuals, corporations and foundations. CIHFI is a 32 year old not-for-profit 501(c)(3) organization located in Wichita, KS.


'/>"/>
SOURCE Bio-Communications Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
3. BioMS Medical Announces 2007 Year End Results
4. First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies OmniWave(TM) Endovascular System
5. GHI Medical Deploys New Test to Help Determine Hair Loss
6. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
7. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
8. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
9. Pathway Medical Technologies Names Paul Buckman Chairman of the Board of Directors
10. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
11. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):